We read with interest the recent review of medical use of cannabinoids (1). As the authors attempt to emphasize, they focus on a heterogeneous collection of experiments that employed a range of treatments, including synthetic THC, CBD, and THC-mimicking drugs.
Lay readers might inappropriately generalize these results specifically to whole plant medical cannabis But few (only two) of these experiments were conducted using medical cannabis; most of the studies reviewed focused on outcome measures that do not address the plant’s potential advantages over a single, compound agent in pill form.
For example, the authors conclude that evidence of individual, synthetic cannabinoids to help nausea and vomiting due to chemotherapy was low in quality. Within hours of the publication of the paper, mainstream media coverage applied these conclusions to medical cannabis per se, not just medical cannabinoids (2). In fact, as the authors emphasize, only 6 of the 28 studies assessing nausea and vomiting used THC, and none of these actually employed vaporized or inhaled botanical cannabis. The dependent measures were also not sensitive to the key advantage of medical cannabis for nausea: speed of onset. (Inhaled medicines can work within seconds. Sprayed extracts require at least a half hour while cannabinoids in pill form can take multiple hours.) The authors were generally careful about these caveats, but the disparate and inaccurate media coverage suggests that flagship journals in all fields now have to be even more diligent when cautioning readers about the inappropriate generalization of results. Despite increasing popularity, medical cannabis remains controversial and, apparently, newsworthy. As reviews of the effects of cannabinoids proliferate, authors, editors, journal staff, and journalists might welcome a reminder that cautions about interpretation need to be spelled out in more effusive, detailed, and thorough ways.
Mitch Earleywine, Ph.D.
University at Albany
Department of Psychology
Chair, NORML Board of Directors
National Organization for the Reform of Marijuana Laws (NORML)
Amanda Reiman, Ph.D.
Drug Policy Alliance
1) Whiting PF, Wolff RF, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA, 2015: 313(24):2456-2473
2) Seaman, AM. Medical marijuana: good evidence for some diseases, weak for others. Reuters. June 24, 2015. http://www.reuters.com/article/2015/06/23/us-marijuana-medical-evidence-idUSKBN0P31WT20150623
While America’s public support for domestic prohibition of marijuana appears increasingly waning, quantifying the types of marijuana law reforms internationally could constitute a full time job for the eager.
This day’s news alone from overseas about cannabis law reforms strongly suggests that the contagion to end pot prohibition is hardly an America-only phenomena:
Israel – The country’s deputy health minister announced today that medical cannabis will be made available for retail access via commercial pharmacies.
Italy – Cannabis law reform group in Italy claims 250 out of 945 members of Italian Parliament support ending pot prohibition, which is a little more than twenty-five percent of the country’s elected policymakers. Drafted by the Intergrupo Parlamentare Cannabis Legale, the legislation would allow anyone over the age of 18 to cultivate as many as five plants at home. Italians could also team up to form a “cannabis social club,” with each having a maximum of 50 people growing as many as 250 plants.
Surveys in Italy indicate that nearly eighty percent of citizens support the country adopting marijuana laws similar to American states Colorado and Washington.
United Kingdom – A twenty-five year old economics student in the United Kingdom has forced the hand of parliament to debate the issue of marijuana legalization by submitting a petition with over one hundred thousand signatures.
Australia’s Queensland – Joining New South Wales, the Australian state of Queensland took steps to formalize a system by which qualified medical patients can access cannabis products via a series of research trials.
Portugal – California’s Press Enterprise’s editorial board reminds all that the week marks the fourteenth anniversary of the first nation, Portugal, to entirely decriminalize drug use and possession, which is serving as a ‘harm reduction’ model for numerous countries.
It is hardly a secret to any long observing advocate for cannabis law reform to recognize early on in their efforts to end cannabis prohibition that if it were not for government–federal, state and local governments–spending, there would be relatively few examples of private money being employed in the last forty-five years to try to maintain the status quo of cannabis prohibition.
The tens of billions spent annually to keep the Reefer Madness going in America largely is taxpayer-funded bureaucracies such as the so-called drug czar’s office, DEA, NIDA, SAMHSA, DARE, PDFA…blah–blah–blah.
Even in the face of this tremendous waste of taxpayer dollars annually, still, a majority of the US public rejects the policy of cannabis prohibition.
Unbelievably, the drug czar’s office actually mandates that the office must use tax funding to publicly oppose cannabis legalization efforts–even though such is no longer a popularly supported public policy.
Add one more prime example of cannabis prohibitionists in government not yielding to the will of voters, and worse, rather than pool their own private funding to advance their no-longer-popular-views, they want the taxpayers to pick up the bill of their anti-cannabis advocacy.
Arizona voters approved a medical cannabis initiative in 2010. Many in the law enforcement community in the state, including prosecutors, have consistently opposed implementing the change of policies and/or still harass medical cannabis producers or patients.
They’re sore losers.
Now, consistent with large swaths of the country, Arizona voters are organizing once again in the state to place a full cannabis legalization initiative on the ballot for 2016.
What is the reaction from some in the law enforcement community in Arizona to the prospects of citizens again instructing their workers what public policies they want them to enforce?
Sure, law enforcement personnel are citizens too, and their opinions are as meaningful as any other citizens’, however, law enforcement personnel who oppose the public’s will on changes of public policy should never employ taxpayer funding to try to sway the populace or propagandize–on matters ranging from police wearing body cameras, to forfeiture reform to cannabis legalization.
Well that is not at all happening currently in Yavapai County Arizona, where the local prosecutor Shelia Polk thinks it wise and prudent to steer forfeiture money derived from the criminal justice system (with most of the proceeds coming to law enforcement from currently illegal drug profits seized in previous criminal filings) to propagandize to voters that they should not vote to end cannabis prohibition in the state.
Ever hear law enforcement roll out the tired ol’ line of “we don’t make the laws, we only enforce them?”
It’s largely a lie (I mean…prevarication).
Police and prosecutors (aided and abetted by fellow pot prohibitionists wearing white coats at NIDA, for example) regularly, using taxpayers’ money, actively seek to influence the outcome of public policy legislation, court cases and voter initiatives that seek to reform cannabis laws.
It is pretty simple at this point in the now five-decade-old public effort to end cannabis prohibition, if police and prosecutors want to defend the status quo of a failed and unpopular public policy, then, if they really cared about the issue, they’d put their own skin in the game by organizing as private citizens.
If prosecutors, cops, narcs, sheriffs and chiefs of police want to pony up their own money to try to stave off cannabis prohibition ending in their lifetimes–go for it.
Reformers will more than match them dollar-for-dollar and are always spoiling for a good debate about wisdom for rationale continuing cannabis prohibition…and we’ve got the public on our side, they no longer do.
What can not and should not happen anymore in the modern public policy debate about whether America should or should not continue another nearly eighty-years with cannabis prohibition enforcement are government officials and law enforcement personnel using their power of the purse and bully pulpit to try to persuade voters on ANY matters of public policy–let alone on policies where conflicts of interest are as obvious as prosecutors using government money to oppose the will of local voters who’re seeking to reform unpopular laws.
Cannabis law reformers can and will win a fair fight on cannabis legalization, but, the impending political victory will be delayed if government officials are permitted to continue to use taxpayer funding to oppose the very will of the voters.
Government for and by the people? Not when government officials are sore losers and want to use government funding to try to tip the scales of public opinion.
When government stops spending taxpayer dollars to keep cannabis prohibition going, the unpopular policy will die an ignominious and swift death.
Editor’s note: Thankfully, late yesterday AZ’s Attorney General came to reconsider this blundering policy of allowing government funding to be used to campaign against cannabis legalization efforts in the state.
A new report by the Institute of Taxation and Economic Policy (ITEP) adds considerable information to the base knowledge accumulating at the state level on new changes in laws and custom regarding cannabis legalization circa 2013, starting in the states of Colorado and Washington after citizens voted to end cannabis prohibition via binding ballot initiatives.
ITEP’s principle donors are found here.
Tomorrow’s Sunday New York Times’ editorial calling for an end to cannabis prohibition in America, affirms in my mind, after nearly twenty four years publicly advocating for cannabis law reforms at NORML, the end of cannabis prohibition in our nation is nearly upon the rest of the country (beyond Colorado and Washington State, where cannabis is taxed and regulated like alcohol products for responsible adult use). This is the same editorial board and opinions page that would with great frequency in the 1980s/90s publish some of the most stridently pro-cannabis prohibition editorials and columns found anywhere in the world, let alone from the urbane and ‘liberal’ New York Times, led by ardent cannabis foe, former editor and columnist A.M. Rosenthal.
Also included, informative editorial writing and excellent up-to-date map of all of the variations on cannabis law reform that have happened at the state level, putting evermore upward political pressure on the federal government to both end cannabis prohibition and severely down schedule the herbal drug.
Lastly, the dramatic change in Americans’ public attitude in favor of ending cannabis prohibition is well documented here.
A great sign of the times…the multidimensional pro-reform editorial ends with this nod to cannabis culture: On Monday at 4:20 p.m. Eastern Time, Andrew Rosenthal, the editorial page editor, will be taking questions about marijuana legalization at facebook.com/nytimes.
Andrew Rosenthal…the son of A.M. Rosenthal.
Times in America regarding cannabis have changed, and, accordingly, so too has the New York Times.